Publications & Research Interests

Published Research

Hurst WJ, M Rogosnitzky, PJ McLaughlin, and IS Zagon.  The stability of opioid growth factor ([Met5]-enkephalin) in solution using HPLC and photodiode array detection. J. Liquid Chromatography & Related Technologies, 2006; 29:1-7. [Journal]

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS.  Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol. 2007 Apr;102(4):820-8. [PubMed]

Zagon I, Donahue RN, Rogosnitzky M, McLaughlin PJ.  Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function. Exp Biol Med (Maywood). 2008;233: 968-979 . [PubMed]

Barken I, Geller J, Rogosnitzky MNoscapine inhibits human prostate cancer progression and metastasis in a mouse model. Anticancer Res. 2008;28(6A):3701-3704. [PubMed]

Barken I, Geller J, Rogosnitzky MProphylactic noscapine inhibits prostate cancer in a mouse model. Anticancer Res. 2010;30(2):399-401. [PubMed]

Rogosnitzky M, Danks R  Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer. A short review.   In Press

 

Research Interests

 

Patents

TREATMENT OF INFLAMMATORY AND ULCERATIVE DISEASES OF THE BOWEL WITH OPIOID ANTAGONISTS (Pending)

METHOD OF WOUND TREATMENT USING LIQUID GALLIUM NITRATE (Pending)